Article
Risk-Reducing Interventions in Women With Pathogenic Variants in Breast Cancer Susceptibility Genes.
JCO precision oncology - 1 Aug 2026
Russell Emily M, Nielsen Sarah M, Ellsworth Rachel E, Chwan Ko Heidi, Previs Rebecca A, Pineda-Alvarez Daniel E, Esplin Edward D, Hughes Kevin, Gray Stacy W, Tung Nadine M, Kurian Allison W
Abstract excerpt
PURPOSE: Recommendations for clinical management of women with germline pathogenic variants (PVs) in breast cancer susceptibility genes vary by gene. The goal of this study was to examine the utilization of risk-reducing strategies and treatments in women with germline PVs in breast cancer susceptibility genes. METHODS: This cross-sectional study identified women with a PV in at least one of 13 breast cancer...
Topics
Join the communities discussing this publication.
